Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Huajin Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$53M
Portfolio companies 23
Rounds per year 0.72
Lead investments 5
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Semiconductor
Summary

Huajin Capital appeared to be the VC, which was created in 1992. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Zhuhai.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Huajin Capital, startups are often financed by Qiming Venture Partners, IDG Ventures, Highlight Capital. The meaningful sponsors for the fund in investment in the same round are Xunlei, Suning, Qiming Venture Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Virtual Reality, Video. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Suzhou Kintor Pharmaceuticals, Insta360. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Huajin Capital:
Typical Co-investors
Huajin Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Huajin Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
37 Interactive Entertainment China, Shanghai
42 Ventures Salt Lake City, United States, Utah
BA Ventures -
Broadway Partners Connecticut, Greenwich, United States
Canopy Group Le Sueur, Minnesota, United States
Capital Nature Israel, Tel Aviv, Tel Aviv District
DOCOMO Innovations California, Palo Alto, United States
ECC Capital Beijing, Beijing, China
Global Retail Brands Australia, Melbourne, Victoria
Infema Barcelona, Catalonia, Spain
Modern Capital China, Shanghai
National Skill Development Corporation Delhi, India, New Delhi
Pathfinder Venture Capital Funds Minneapolis, Minnesota, United States
Ririshun Lejia Home Furnishing Trade China, Qingdao Shi, Shandong
Siraj Fund Management Company Area A, Palestinian Territory, West Bank
Suncorp Group Australia, Brisbane, Queensland
TenEleven Ventures Burlingame, California, United States
Xinhe Capital Beijing, Beijing, China
Zhenshun Jijin Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Medinno

Biopharma
Biotechnology
Wellness
16 Jan 2024 Xinxiang, Henan, China

Innovo Therapeutics

Biotechnology
Medical
Product Research
$15M01 Dec 2023 San Diego, California, United States

Baoling Bio

Biopharma
Biotechnology
Medical
Pharmaceutical
24 Nov 2023 Chengdu, Sichuan, China

Zhongke Hydroyi

Information Technology
11 Jul 2023 Ningbo, Zhejiang, China

Eccogene

Health Care
$27M12 Jun 2023 Shanghai, China

Yuefang Technology

Electronics
Power Grid
Semiconductor
$15M10 Apr 2023 Foshan, Guangdong, China

Yinuo Pharmaceutical

Biotechnology
Medical
Pharmaceutical
$6M02 Feb 2023 Hangzhou, Zhejiang, China

HAAWKING

Artificial Intelligence
Industrial
Information Technology
$13M23 Dec 2022 Haidian District, Beijing, China

Beilai Bio

$46M15 Apr 2022 Irvine, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Huajin Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 53M
Rounds per year 0.72
Peak activity year 2023
Lead investments 5
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Medinno

Biopharma
Biotechnology
Wellness
16 Jan 2024 Xinxiang, Henan, China

Innovo Therapeutics

Biotechnology
Medical
Product Research
$15M01 Dec 2023 San Diego, California, United States

Baoling Bio

Biopharma
Biotechnology
Medical
Pharmaceutical
24 Nov 2023 Chengdu, Sichuan, China

Zhongke Hydroyi

Information Technology
11 Jul 2023 Ningbo, Zhejiang, China

Eccogene

Health Care
$27M12 Jun 2023 Shanghai, China

Yuefang Technology

Electronics
Power Grid
Semiconductor
$15M10 Apr 2023 Foshan, Guangdong, China

Yinuo Pharmaceutical

Biotechnology
Medical
Pharmaceutical
$6M02 Feb 2023 Hangzhou, Zhejiang, China

HAAWKING

Artificial Intelligence
Industrial
Information Technology
$13M23 Dec 2022 Haidian District, Beijing, China

Beilai Bio

$46M15 Apr 2022 Irvine, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: